Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 221 of the 226 references it cites were found in a registry or an index; 49 of the 108 sources its claims cite were checked for support.

Effects of Skeletal Muscle Hypertrophy on Fat Mass and Glucose Homeostasis in Humans and Animals: A Narrative Review with Systematic Literature Search

Open access

Abstract

Overweight, obesity, and type 2 diabetes mellitus are metabolic health problems and diseases that affect billions of people worldwide. Studies in animals and humans suggest that stimulating global muscle hypertrophy could be a treatment for these diseases, as some key studies suggest that stimulation of global muscle hypertrophy commonly reduces fat mass and improves glucose homeostasis. To analyse the effect of muscle hypertrophy on fat and glucose homeostasis in more detail, we systematically searched the literature and quantitatively analyzed 122 studies (humans: n = 99; animals: n = 23). This analysis reveals that a 1.9–3.3% increase in global muscle mass in humans is associated with 4.1 ± 5.8% lower fat mass, a mean relative reduction in HbA1c of 4.1 ± 4.6% from baseline, and a reduction of fasting glucose concentrations by 5.8 ± 7.3% in studies lasting 2 weeks to 3 years. In the animal studies analyzed, the researchers increased muscle mass by transgenesis, drugs, or resistance training by 17.7 ± 18.4%. This increase of muscle mass was associated with 23.7 ± 22.3% less fat mass. In the second part of this review, we discuss mechanisms by which muscle hypertrophy can affect fat mass and glucose homeostasis. We also discuss the potential use of hypertrophy-focused resistance training and muscle hypertrophy-stimulating drugs as treatments for people with overweight, obesity, and type 2 diabetes.

Overview

CoChat Summary

## TL;DR

This narrative review with a systematic literature search found that global skeletal muscle hypertrophy is associated with lower fat mass and improved glucose homeostasis in both humans and animals. The human evidence was strongest for fat loss and fasting glucose/HbA1c improvements with resistance training, while animal studies more consistently supported a direct link between increased muscle mass and better glucose control.

## Key findings

  • The systematic search identified 122 studies total: 99 human and 23 animal intervention studies.
  • In human studies, a 1.9–3.3% increase in global muscle mass was associated with 4.1 ± 5.8% lower fat mass, a mean relative HbA1c reduction of 4.1 ± 4.6%, and a 5.8 ± 7.3% reduction in fasting glucose across studies lasting 2 weeks to 3 years.
  • For human fat mass, the review reports an overall inverse association between muscle hypertrophy and fat loss (R² = 0.25, r = −0.51, p < 0.001); within subgroups, the association remained significant across BMI, age, and training-experience strata.
  • In animal studies, muscle hypertrophy increased muscle mass by 17.7 ± 18.4% and was associated with 23.7 ± 22.3% less fat mass; glucose outcomes showed 16.1 ± 18.7% lower blood glucose overall, though the regression across all animal data was not significant (R² = −0.09, r = −0.10, p = 0.762).
  • The paper highlights a human randomized trial of bimagrumab in people with type 2 diabetes and BMI 28–40 kg/m², where lean mass increased by 1.70 kg, fat mass fell by 7.49 kg, and HbA1c decreased by 0.76%.

## Methods

  • Narrative review plus systematic literature search using PubMed/MEDLINE, SPORTDiscus, and Scopus on 17 September 2024, with English-language, peer-reviewed studies that induced global muscle hypertrophy in humans, animals, or transgenic models.
  • Included studies had to report changes in fat mass or glucose metabolism (HbA1c or blood glucose); the review analyzed 122 studies in total.
  • Main analyses were quantitative summaries and linear regressions/correlation analyses relating changes in muscle mass to changes in fat mass or glucose outcomes, with subgroup analyses by BMI, age, and training experience.

## Limitations

  • The authors state that they had previously “cherry picked” supportive studies, creating a risk of bias, which is why they conducted the systematic search.
  • They note that exercise itself can reduce fat mass and improve glucose homeostasis, making it difficult to disentangle the direct effect of hypertrophy from the effects of training; this limitation is explicitly discussed in the paper.
  • The human glucose literature was limited for pharmaceutical-only interventions: only a single human study met the criterion of no exercise component, and the authors report that no regression analyses were performed for that group.
  • The paper also makes evident that some interventions act on muscle and adipose tissue simultaneously (for example β-adrenergic agonists and testosterone), which limits causal attribution to muscle hypertrophy alone.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1007/s40279-025-02263-w

Cites

221 of 222 references verified0 citation errors · 1 not checkable

Statistics

Nothing to recompute.

Figures

Fig. 1 Muscle building and fat lowering effects of repartitioning agents and myostatin inhibition. A Cross-sections at the 10th rib of pigs [19]. Left represents a pig treated with 3 mg clenbuterol/kg feed for 4 weeks, plus a 3-week course of daily injections of 0.1 mg recombinant porcine growth hormone/kg liveweight. Right represents a typical control animal. B Belgian blue bull showing double muscling and low fat mass. These animals have “natural” mutations of the muscle mass-inhibiting Mstn gene. [Copyright (1997) National Academy of Sciences] [20]
Fig. 1 Muscle building and fat lowering effects of repartitioning agents and myostatin inhibition. A Cross-sections at the 10th rib of pigs [19]. Left represents a pig treated with 3 mg clenbuterol/kg feed for 4 weeks, plus a 3-week course of daily injections of 0.1 mg recombinant porcine growth hormone/kg liveweight. Right represents a typical control animal. B Belgian blue bull showing double muscling and low fat mass. These animals have “natural” mutations of the muscle mass-inhibiting Mstn gene. [Copyright (1997) National Academy of Sciences] [20]CC BY · PubMed Central
Fig. 2 Scatter plots of the effect of muscle hypertrophy on fat mass changes. A represents changes in muscle mass/fat mass from pre- to post-intervention in humans. The green dashed line indicates the regression line of the pharmaceutical treatment (n = 15, k = 21), while the black dashed line includes all other treatments (n = 82, k = 109). The size of each data point represents the sample size. B represents relative differences in muscle mass versus relative differences in fat mass between experimental group and controls in animal models. The green dashed line indicates the regression line of the pharmaceutical treatment (n = 5, k = 9), while the black dashed line includes all other treatments (n = 16, k = 23)
Fig. 2 Scatter plots of the effect of muscle hypertrophy on fat mass changes. A represents changes in muscle mass/fat mass from pre- to post-intervention in humans. The green dashed line indicates the regression line of the pharmaceutical treatment (n = 15, k = 21), while the black dashed line includes all other treatments (n = 82, k = 109). The size of each data point represents the sample size. B represents relative differences in muscle mass versus relative differences in fat mass between experimental group and controls in animal models. The green dashed line indicates the regression line of the pharmaceutical treatment (n = 5, k = 9), while the black dashed line includes all other treatments (n = 16, k = 23)CC BY · PubMed Central
Fig. 3 Scatter plots of the effect of muscle hypertrophy on glucose homeostasis. The dashed lines indicate the linear regression. A represents changes in muscle mass and fasted glucose or HbA1c concentrations from pre- to post-intervention in humans (n = 22, k = 31). The size of each data point represents the sample size. B represents relative differences in muscle mass versus differences in blood glucose concentration between experimental groups and controls in animal models (n = 10, k = 12)
Fig. 3 Scatter plots of the effect of muscle hypertrophy on glucose homeostasis. The dashed lines indicate the linear regression. A represents changes in muscle mass and fasted glucose or HbA1c concentrations from pre- to post-intervention in humans (n = 22, k = 31). The size of each data point represents the sample size. B represents relative differences in muscle mass versus differences in blood glucose concentration between experimental groups and controls in animal models (n = 10, k = 12)CC BY · PubMed Central
Fig. 4 Mechanisms that explain the effects of muscle hypertrophy on fat mass and glucose homeostasis. A Akt1 and myostatin are examples of regulators whose action on muscle is enough to cause a loss of fat mass and improvement of glucose homeostasis. B In contrast, the catecholamines adrenaline and noradrenaline, as well β-adrenergic agonists, act both on skeletal muscle and adipose tissue as both tissues express adrenergic receptors. C Inter-organ signal transduction mechanisms (e.g., in response to resistance exercise) versus D metabolic mechanisms (e.g., β-adrenergic agonist effects on skeletal muscle and adipose tissue metabolism; [170]) that can potentially explain the effects of muscle hypertrophy on fat and glucose
Fig. 4 Mechanisms that explain the effects of muscle hypertrophy on fat mass and glucose homeostasis. A Akt1 and myostatin are examples of regulators whose action on muscle is enough to cause a loss of fat mass and improvement of glucose homeostasis. B In contrast, the catecholamines adrenaline and noradrenaline, as well β-adrenergic agonists, act both on skeletal muscle and adipose tissue as both tissues express adrenergic receptors. C Inter-organ signal transduction mechanisms (e.g., in response to resistance exercise) versus D metabolic mechanisms (e.g., β-adrenergic agonist effects on skeletal muscle and adipose tissue metabolism; [170]) that can potentially explain the effects of muscle hypertrophy on fat and glucoseCC BY · PubMed Central

Verification

Claims the paper makes

38 Valid · 2 Not valid · 34 Not checked · 76 Own results and interpretations

106 more claims · 18 with their cited sources checked

Create a free account to see all 150 claims and every source verdict.

See all claims — free account
  • It may state two separate claims as one. 32
  • Probably not a substantial claim. 13

Create a free account to see these claims.

Citations

Cites

Show all 226 references

Research works printed but not linked: 2

  1. WHO. WHO guidelines on physical activity and sedentary behaviour. Geneva: World Health Organization; 2020.
  2. Cavalie H, Mounier R, Clottes E, Bricout V, Lac G. Clenbuterol treatment differently affects muscle in exercised or sedentary rats. J Exerc Physiol Online. 2004;7:111–20.

Cited by

See all 19

Metadata

Authors
Havers, T., Held, S., Schönfelder, M., Geisler, S., & Wackerhage, H.
Affiliations
Technical University of Munich (DE)
Corresponding author
Havers, Tim
Venue
Sports Medicine
Published
2025-06-27
Volume
55
Issue
8
Pages
1867-1885
ISSN
  • 0112-1642 (ISSN-L)
  • 1179-2035
OpenAlex
W4411687406
Cited by
19
References
226
Citations by year
2026: 17 · 2025: 2
FWCI
1.67
Type
journal article
Language
en
Open access
Licence
Locations
  • Sports Medicine (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
  • mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion, other-oa)
Funders
Technische Universität München
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
Keywords
skeletal muscle hypertrophy, fat mass, glucose homeostasis, obesity, type 2 diabetes, overweight, resistance training, HbA1c, fasting blood glucose
MeSH terms
Skeletal Muscle Enlargement, Adipose Tissue, Animals, Blood Glucose, Diabetes Mellitus, Type 2, Glucose, Glycated Hemoglobin, Homeostasis, Humans, Hypertrophy, Obesity, Muscle, Skeletal, Resistance Training

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of Skeletal Muscle Hypertrophy on Fat Mass and Glucose Homeostasis in Humans and Animals: A Narrative Review with Systematic Literature Search. https://app.cochat.ai/papers/10.1007/s40279-025-02263-w
The paper
Havers, T., Held, S., Schönfelder, M., Geisler, S., & Wackerhage, H. (2025). Effects of Skeletal Muscle Hypertrophy on Fat Mass and Glucose Homeostasis in Humans and Animals: A Narrative Review with Systematic Literature Search. Sports Medicine. https://doi.org/10.1007/s40279-025-02263-w

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.